Neuren Pharmaceuticals | NEU - Operating Expenses

Stock Price
12.24
Daily Change
-0.36 -2.86%
Monthly
-29.45%
Yearly
-8.59%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD8.69M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Genetic Signatures AUD 8.3M 16.23M Jun/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
Medical Developments International AUD 10.02M 9.78M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Organon & Co USD 906M 362M Sep/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Starpharma Holdings AUD 4.01M 3.81M Jun/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025
Viatris USD 3.53B 128.7M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025